Abstract | OBJECTIVES: Our purpose was to determine whether the common polymorphisms (SNP-604, SNP1192, and SNP1719) in KDR are associated with risk of coronary heart disease. BACKGROUND: METHODS: The association of the 3 polymorphisms with risk of coronary heart disease was determined in 2 independent case-control studies: one comprised of 665 patients with coronary heart disease and 1,015 control subjects, and the other comprised of 369 patients and 625 control subjects. The SNP functions of KDR gene were studied by using luciferase reporter assays, determination of serum levels of KDR, and ligand-binding assays. RESULTS: The 2 independent population studies showed that the 3 polymorphisms were associated with risk of coronary heart disease with odds ratios of 1.37 for SNP-604 (p = 0.006), 1.41 for SNP1192 (p = 0.011), and 1.37 for SNP1719 (p = 0.007) in the first population, and 1.40 for SNP-604 (p = 0.015), 1.75 for SNP1192 (p = 0.003), and 1.50 for SNP1719 (p = 0.010) in the second population. The SNP-604C-bearing KDR promoter exhibited 68% of lower transcription activity than the SNP-604T-bearing promoter. The SNP1192 and SNP1719 could obviously influence the efficiency of VEGF binding to KDR. CONCLUSIONS:
|
Authors | Yibo Wang, Yi Zheng, Weili Zhang, Hui Yu, Kejia Lou, Yu Zhang, Qin Qin, Bingrang Zhao, Ying Yang, Rutai Hui |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 50
Issue 8
Pg. 760-7
(Aug 21 2007)
ISSN: 1558-3597 [Electronic] United States |
PMID | 17707181
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Genetic Markers
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor Receptor-2
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Case-Control Studies
- China
- Coronary Disease
(genetics)
- Female
- Genetic Markers
- Genetic Predisposition to Disease
- Genotype
- Humans
- Male
- Middle Aged
- Mutation, Missense
- Polymorphism, Single Nucleotide
- Promoter Regions, Genetic
- Transcription, Genetic
- Vascular Endothelial Growth Factor A
(metabolism)
- Vascular Endothelial Growth Factor Receptor-2
(blood, genetics, metabolism)
|